MELBOURN, England, June 22, 2015 /PRNewswire/ --
Aegate, the leading experts in medicines verification, held a Falsified Medicines Directive (FMD) information seminar with the Romanian stakeholders at the British Embassy in Bucharest.
Over 50 people from all local stakeholder organisations attended this important meeting. Aegate presented information on the FMD as well as practical insight gained in running medicines authentication services in Belgium, Greece and Italy, where over 3.3 billion medicines have been checked with Aegate's state of the art authentication service.
Implementation of a national verification system in Romania is a vital stepping stone to patient safety and decisions can be made now for local needs. Aegate is ready to deploy at both European and national levels, and looks forward to continued collaboration with the Romanian stakeholders.
With a documented history of some 3.3 billion medicines scanned to date with an average rate of 200,000 transactions per hour across 20,000 dispensing points, Aegate is the principal active market leader in medicines verification. Aegate's Reach, Assure and Protect services meets the needs of all stakeholders. Supported internationally by manufacturers and pharmacists alike, Aegate is a European company with offices throughout Europe. Our mission is to protect patients from falsified, recalled or expired medicines.
We operate a highly secure real‐time system to verify the authenticity of medicines. This operates seamlessly from manufacturer to pharmacy, and fully meets the requirements of European legislation for falsified medicines. The Aegate network also supports messaging services that provide additional information for the pharmacist at the point of dispense, such as regulatory or drug safety advice and patient education or adherence information.
For more information on Aegate, please visit http://www.aegate.com
Media contact information: Miriam Foster
Head of Marketing & Communications